Perindopril Erbumine
NDC 65862-286, Perindopril Erbumine, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 65862-286
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079070
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PERINDOPRIL ERBUMINE2 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-286-01 | 65862028601 | 100 TABLET in 1 BOTTLE (65862-286-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/87768fbf-7c63-47da-8925-0316f343d6efNADAC price for package 65862028601
GET /v1/drugs/nadac/65862028601
Use it
Look up 65862-286 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.